Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine. P.G.P. Machado, C.R. Felipe, S.I. Park, R. Garcia, S. Moreira, D. Casarini, M. Franco, F. Alfieri, H. Tedesco-Silva Jr. and J.O. Medina-Pestana. Brazilian Journal of Medical and Biological Research, 37 (9): 1303, 2004.
Figure 1. Mean cyclosporine daily doses (A) and trough whole blood concentrations (B) in patients receiving sirolimus (squares) or azathioprine (circles). *P < 0.05 comparing mean values at each time of transplant (unpaired Student t-test).